These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23649686)

  • 1. Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review.
    Rachaneni S; Arya P; Latthe P
    Int Urogynecol J; 2013 Oct; 24(10):1603-9. PubMed ID: 23649686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
    Seth JH; Sahai A; Khan MS; van der Aa F; de Ridder D; Panicker JN; Dasgupta P; Fowler CJ
    BJU Int; 2013 Mar; 111(3):372-80. PubMed ID: 23444927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.
    Silva-Ramos M; Silva I; Oliveira O; Ferreira S; Reis MJ; Oliveira JC; Correia-de-Sá P
    PLoS One; 2013; 8(5):e64696. PubMed ID: 23741373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could urinary nerve growth factor be a biomarker for overactive bladder? A meta-analysis.
    Sheng W; Zhang H; Ruth KH
    Neurourol Urodyn; 2017 Sep; 36(7):1703-1710. PubMed ID: 28102552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary nerve growth factor: a biomarker for detrusor overactivity in children? A meta-analysis and trail sequential analysis.
    Deng C; Zhang W; Peng Q; Hu X; Li M; Gao L; Xu J; Su J; Xia X
    Pediatr Surg Int; 2019 Sep; 35(9):1027-1032. PubMed ID: 30729304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
    Krivoborodov GG; Kolesanova EF; Tur EI; Efremov NS
    Urologiia; 2015; (3):19-22. PubMed ID: 26390554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis].
    Bazhenov IV; Filippova ES; Bazarnyi VV; Sazonov SV; Volkova LI; Zaitseva LN
    Urologiia; 2018 Jul; (3):44-48. PubMed ID: 30035417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Liu HT; Chancellor MB; Kuo HC
    Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary nerve growth factor and a variable solifenacin dosage in patients with an overactive bladder.
    Ciftci S; Ozkurkcugil C; Yilmaz H; Ustuner M; Yavuz U; Yuksekkaya M; Cekmen MB
    Int Urogynecol J; 2016 Feb; 27(2):275-80. PubMed ID: 26310546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC; Liu HT; Chancellor MB
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis.
    Qu HC; Zhang W; Yan S; Liu YL; Wang P
    PLoS One; 2014; 9(9):e106321. PubMed ID: 25181532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker.
    Oktar T; Kocak T; Oner-Iyidogan Y; Erdem S; Seyithanoglu M; Ziylan O; Kocak H
    J Pediatr Urol; 2013 Oct; 9(5):617-21. PubMed ID: 22789557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
    Kim SR; Moon YJ; Kim SK; Bai SW
    Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have we been led astray by the NGF biomarker data?
    Gamper M; Moser R; Viereck V
    Neurourol Urodyn; 2017 Jan; 36(1):203-204. PubMed ID: 26384156
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic value of nerve growth factor in detrusor overactivity: a study on women with mixed urinary incontinence.
    Salehi-Pourmehr H; Ghojazadeh M; Jahantabi E; Hajebrahimi S
    Int Urol Nephrol; 2021 Aug; 53(8):1557-1562. PubMed ID: 33866484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.
    Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM
    J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Nerve Growth Factor Can Predict Therapeutic Efficacy in Children With Overactive Bladder.
    Fukui S; Aoki K; Morizawa Y; Miyake M; Fujimoto K
    Urology; 2017 May; 103():214-217. PubMed ID: 28161379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
    Liu HT; Kuo HC
    Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.